Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Edward Morrow Atkinson III

At a glance: Edward Morrow Atkinson III is Evp, Chief Technical Ops. Off. at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Feb 26, 2026, reported a sale of $325K. On file: 0 purchase lines ($0) and 5 sale lines ($3.6M).

Disclosed holdings: about $9.6M of VRTX stock: 18,432 shares reported on their latest Form 4 (filed Feb 26, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp, Chief Technical Ops. Off. at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.6M

Edward Morrow Atkinson III's InsiderPrint

5 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Edward Morrow Atkinson III: 5 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 4 sales

Reading this print: Almost only sells, trading about 5 times a year, typically $806K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (5)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Christopher Scott EdmondsPresident · ICE · 100% match
  2. Ingrid DelaetChief Regulatory Officer · NBIX · 100% match
  3. Mark E. BunnageEvp, Chief Scientific Officer · VRTX · 100% match
  4. Shibu NinanChief Accounting Officer · OKTA · 99% match
  5. Jane PriorChief Marketing Officer · COCO · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Feb 26SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 66818,432 held (−3%) $486.35 $325K +7.2%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,03121,544 held (−9%) $489.46 $994K +6.5%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 81720,727 held (−4%) $473.68 $387K +10.1%
Feb 12SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,75122,046 held (−7%) $460.43 $806K +13.2%
Nov 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,50016,852 held (−13%) $434.58 $1.1M +20.0%
  • Sell

    Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $325K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $994K of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $387K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $806K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $1.1M of VRTX at $434.58 — pre-scheduled 10b5-1 plan sale.

Follow Edward Morrow Atkinson III

Get one email when Edward Morrow Atkinson III files a new purchase or sale. Free.

At most one email a day about Edward Morrow Atkinson III, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.